Ironsides Asset Advisors’s Zimmer Biomet ZBH Stock Holding History

Ironsides Asset Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-13,453	Closed	-$1.35M	–	149
2016 Q4	$1.35M	Hold	13,453	–	–	0.37%	59
2016 Q3	$1.7M	Hold	13,453	–	–	0.46%	49
2016 Q2	$1.57M	Hold	13,453	–	–	0.48%	44
2016 Q1	$1.39M	Buy	13,453 +712	+6%	+$68.9K	0.35%	61
2015 Q4	$1.27M	Buy	12,741 +31	+0.2%	+$3.03K	0.34%	61
2015 Q3	$1.16M	Hold	12,710	–	–	0.32%	62
2015 Q2	$1.35M	Hold	12,710	–	–	0.38%	60
2015 Q1	$1.45M	Sell	12,710 -26	-0.2%	-$2.97K	0.39%	56
2014 Q4	$1.4M	Hold	12,736	–	–	0.39%	58
2014 Q3	$1.24M	Sell	12,736 -15	-0.1%	-$1.48K	0.36%	61
2014 Q2	$1.29M	Buy	+12,751	New	+$1.24M	0.37%	58

Other funds holding ZBH

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ironsides Asset Advisors's ZBH Position: Q1 2017 in Review

Ironsides Asset Advisors sold out of Zimmer Biomet (ZBH) in Q1 2017, closing a stake of 13,453 shares — an estimated $1.35M sold.

Ironsides Asset Advisors first reported a position in ZBH in Q2 2014 and held it in 11 quarters. The position peaked at $1.7M in Q3 2016. 817 funds tracked by Wall St. Rank hold ZBH as of Q1 2017.

Ironsides Asset Advisors reported no remaining Zimmer Biomet position as of Q1 2017 after selling out during the quarter.
Ironsides Asset Advisors sold 13,453 Zimmer Biomet shares in Q1 2017, an estimated $1.35M.
Ironsides Asset Advisors first reported a position in Zimmer Biomet in Q2 2014 and held it in 11 quarters.
Ironsides Asset Advisors's Zimmer Biomet position peaked at $1.7M in Q3 2016.
817 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2017.

Based on Ironsides Asset Advisors's 13F filing for Q1 2017, filed 10 May 2017.